Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$209.01 - $232.56 $166,998 - $185,815
799 Added 2.54%
32,229 $7.04 Million
Q4 2023

Jan 26, 2024

BUY
$197.69 - $227.29 $122,370 - $140,692
619 Added 2.01%
31,430 $7.14 Million
Q3 2023

Oct 17, 2023

BUY
$201.05 - $221.7 $143,549 - $158,293
714 Added 2.37%
30,811 $6.19 Million
Q2 2023

Aug 14, 2023

BUY
$211.93 - $241.33 $257,494 - $293,215
1,215 Added 4.21%
30,097 $7.26 Million
Q1 2023

Apr 21, 2023

BUY
$213.32 - $257.83 $85,114 - $102,874
399 Added 1.4%
28,882 $6.63 Million
Q4 2022

Feb 16, 2023

SELL
$203.72 - $248.97 $224,906 - $274,862
-1,104 Reduced 3.73%
28,483 $6.7 Million
Q3 2022

Oct 28, 2022

BUY
$204.81 - $262.19 $205,629 - $263,238
1,004 Added 3.51%
29,587 $6.06 Million
Q2 2022

Aug 11, 2022

BUY
$213.86 - $277.87 $353,938 - $459,874
1,655 Added 6.15%
28,583 $6.7 Million
Q1 2022

Apr 28, 2022

BUY
$259.82 - $298.18 $723,338 - $830,133
2,784 Added 11.53%
26,928 $7.1 Million
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $796,602 - $921,577
2,933 Added 13.83%
24,144 $7.59 Million
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $440,811 - $494,577
1,604 Added 8.18%
21,211 $5.97 Million
Q2 2021

Aug 13, 2021

BUY
$251.87 - $278.14 $400,221 - $441,964
1,589 Added 8.82%
19,607 $5.41 Million
Q1 2021

May 14, 2021

BUY
$204.88 - $255.03 $205,494 - $255,795
1,003 Added 5.89%
18,018 $4.6 Million
Q4 2020

Feb 12, 2021

BUY
$186.91 - $214.42 $126,164 - $144,733
675 Added 4.13%
17,015 $3.46 Million
Q3 2020

Nov 16, 2020

BUY
$167.03 - $201.3 $188,743 - $227,469
1,130 Added 7.43%
16,340 $3.08 Million
Q2 2020

Aug 06, 2020

BUY
$113.31 - $182.44 $87,248 - $140,478
770 Added 5.33%
15,210 $2.53 Million
Q1 2020

May 13, 2020

SELL
$104.32 - $195.28 $75,214 - $140,796
-721 Reduced 4.76%
14,440 $1.83 Million
Q4 2019

Feb 14, 2020

BUY
$163.48 - $173.61 $34,330 - $36,458
210 Added 1.4%
15,161 $2.57 Million
Q3 2019

Nov 07, 2019

BUY
$159.77 - $178.1 $14,379 - $16,029
90 Added 0.61%
14,951 $2.51 Million
Q2 2019

Aug 02, 2019

BUY
$144.16 - $172.9 $57,952 - $69,505
402 Added 2.78%
14,861 $2.57 Million
Q1 2019

May 10, 2019

BUY
$123.7 - $156.3 $21,647 - $27,352
175 Added 1.23%
14,459 $2.21 Million
Q4 2018

Feb 13, 2019

SELL
$120.82 - $174.09 $62,584 - $90,178
-518 Reduced 3.5%
14,284 $1.81 Million
Q3 2018

Oct 17, 2018

BUY
$167.67 - $188.27 $111,500 - $125,199
665 Added 4.7%
14,802 $2.57 Million
Q2 2018

Aug 17, 2018

BUY
$160.33 - $189.41 $153,115 - $180,886
955 Added 7.24%
14,137 $2.54 Million
Q1 2018

Apr 25, 2018

BUY
$161.53 - $178.11 $89,649 - $98,851
555 Added 4.4%
13,182 $2.13 Million
Q4 2017

Feb 14, 2018

BUY
$147.99 - $163.95 $214,141 - $237,235
1,447 Added 12.94%
12,627 $2.01 Million
Q3 2017

Nov 03, 2017

BUY
$149.47 - $160.56 $1.67 Million - $1.8 Million
11,180
11,180 $1.69 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Ghp Investment Advisors, Inc. Portfolio

Follow Ghp Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghp Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ghp Investment Advisors, Inc. with notifications on news.